| Institution: | 1. Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France;2. Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, INSERM UMR 1138, Paris, France;3. Sorbonne Université, Paris, France;4. Université of Paris, Paris, France;5. Université Paris-Saclay, Villejuif, France;6. INSERM, UMR 1170, Villejuif, France;7. Gustave Roussy Comprehensive Cancer Center, Villejuif, France;8. INSERM, U1015, Villejuif, France;9. Center of Clinical Investigations, CIC1428, Villejuif, France;10. INSERM, U1151, Paris, France;11. CNRS UMR8253, Paris, France;12. Cell Biology and Cancer Unit, Institut Curie, PSL Research University, CNRS, Paris, France;13. Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología (IUOPA), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Universidad de Oviedo, 33006 Oviedo, Spain;14. Suzhou Institute for Systems Medicine, Chinese Academy of Sciences, Suzhou, China;15. Karolinska Institutet, Department of Women’s and Children’s Health, Stockholm, Sweden;16. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France |
